tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Similar Stocks

Compare
278 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$6.63
$402.41M
15.91%
2 Buy
1 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.42
$174.26M
-79.21%
3 Buy
2 Hold
0 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$42.59
$4.03B
-9.00%
15 Buy
1 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$17.77
$1.28B
-62.75%
16 Buy
0 Hold
0 Sell
Strong Buy
Revolution Medicines
$42.26
$7.56B
42.31%
12 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$36.81
$2.42B
-9.09%
7 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GLUE
Monte Rosa Therapeutics
6.63
1.01
17.97%
FATE
Fate Therapeutics
1.42
-5.46
-79.36%
RARE
Ultragenyx Pharmaceutical
44.48
-4.40
-9.00%
ARVN
Arvinas Holding Company
17.77
-28.74
-61.79%
RVMD
Revolution Medicines
41.34
12.29
42.31%
KYMR
Kymera Therapeutics
36.81
-3.68
-9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis